Additives in neuraxial anesthesia: opioids, alpha-2 adrenergic agonists, and neostigmine as a possible future drug for perioperative pain management.
Klimscha
W
W
Department of Anesthesia and General Intensive Care A, University of Vienna, Austria.
Chiari
A
A
Lorber
C
C
Krenn
K
K
Dumitrescu
R
R
Agnese
T
T
D000759:Adjuvants, Anesthesia / Q000008:administration & dosage*; D058647:Adrenergic alpha-2 Receptor Agonists; D000316:Adrenergic alpha-Agonists / Q000008:administration & dosage / Q000627:therapeutic use*; D015360:Analgesia, Epidural; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000627:therapeutic use*; D000767:Anesthesia, Epidural; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D004347:Drug Interactions; D004357:Drug Synergism; D006801:Humans; D007278:Injections, Spinal; D009388:Neostigmine / Q000008:administration & dosage / Q000627:therapeutic use*; D009619:Nociceptors / Q000187:drug effects; D010149:Postoperative Pain / Q000517:prevention & control*
D000759:Adjuvants, Anesthesia; D058647:Adrenergic alpha-2 Receptor Agonists; D000316:Adrenergic alpha-Agonists; D000701:Analgesics, Opioid; D002800:Cholinesterase Inhibitors; D009388:Neostigmine